Biopharmaceuticals power Pfizer in the first quarter
Pfizer is reporting a 9% jump in first quarter profit on a strong showing from its biopharmaceutical group.
Pfizer is reporting a 9% jump in first quarter profit on a strong showing from its biopharmaceutical group.